Abstract
The oxidative metabolism of diethylstilbestrol (DES) and 17α-ethynyl estradiol, as examples of stilbene- and steroid-type estrogens, is discussed with respect to the formation of reactive intermediates. For DES, a genotoxic potential is implied by metabolic studies and positive effects in short-term tests for genetic damage. A particularly important pathway for DES carcinogenicity appears to be peroxidase-mediated oxidation. Although data for steroidal estrogens are more ambiguous, the available evidence suggests that metabolic activation by peroxidatic oxidation may also be of importance for this class of estrogens.
Similar content being viewed by others
Abbreviations
- DES:
-
diethylstilbestrol, 3,4-bis-(p-hydroxyphenyl)hex-3-ene
- E-DES:
-
trans-diethylstilbestrol
- Z-DES:
-
cis-diethylstilbestrol
- DIES:
-
dienestrol, 3,4-bis-(p-hydroxyphenyl)-hexa-2,4-diene (nomenclature of DES metabolites according to the system of Metzler and McLachlan 1978a)
- E1 :
-
estrone
- E2 :
-
estradiol-17ß
- EE2 :
-
17α-ethynylestradiol
- 7,8-BF:
-
7,8-benzoflavone
- GC:
-
gas chromatography
- HPLC:
-
high performance liquid chromatography
- MS:
-
mass spectrometry
References
Abe S, Sasaki M (1977) Chromosome aberrations and sister chromatid exchanges in Chinese hamster cells exposed to various chemicals. J Natl Cancer Inst 58: 1635–1641
Althaus FR, Lawrence SD, Sattler GL, Longfellow DG, Pilot HC (1982) Chemical quantification of unscheduled DNA synthesis in cultured hepatocytes as an assay for the rapid screening of potential chemical carcinogens. Cancer Res 42: 3010–3015
Barrett JC, McLachlan JA, Elmore E (1983) Inability of diethylstilbestrol to induce 6-thioguanine-resistant mutants and to inhibit metabolic cooperation of V79 Chinese hamster cells. Mutat Res 107: 427–432
Barrett JC, Wong A, McLachlan JA (1981) Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 212: 1402–1404
Blackburn GM, Orgee L, Williams GM (1977) Oxidative bonding of natural oestrogens to DNA by chemical and metabolic means. J Chem Soc Chem Comm 11: 386–387
Blackburn GM, Thompson MH, King HWS (1976) Binding of diethylstilboestrol to deoxyribonucleic acid by rat liver microsomal fractions in vitro and in mouse foetal cells in culture. Biochem J 158: 643–646
Bolt HM, Kappus H (1974) Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase. J Steroid Biochem 5: 179–184
Caviezel M, Lutz WK, Minini U, Schlatter C (1984) Interaction of estrone and estradiol with DNA and protein of liver and kidney in rat and hamster. Arch Toxicol 55: 97–103
Clive D, Johnson KO, Spector JFS, Batson AG, Brown MMM (1979) Validation and characterization of the L5178Y/TK+/− mouse lymphoma mutagen assay system. Mutat Res 59: 61–108
Degen GH, Eling TE, McLachlan JA (1982) Oxidative metabolism of diethylstilbestrol by prostaglandin synthetase. Cancer Res 42: 919–923
Degen GH, Wong A, Eling TE, Barrett JC, McLachlan JA (1983) Involvement of prostaglandin synthetase in the peroxidative metabolism of diethylstilbestrol in Syrian hamster embryo fibroblast cell cultures. Cancer Res 43: 992–996
Diamond L, McFall R, Miller J, Gelboin HV (1972) The effects of two isomeric benzoflavones on aryl hydrocarbon hydroxylase and the toxicity and carcinogenicity of polycyclic hydrocarbons. Cancer Res 32: 731–736
Drevon C, Piccoli C, Montesano R (1981) Mutagenicity assays of estrogenic hormones in mammalian cells. Mutat Res 89: 83–90
Glatt HR, Metzler M, Oesch F (1979) Diethylstilbestrol and 11 derivatives. A mutagenicity study with Salmonella typhimurium. Mutat Res 67: 113–121
Gottschlich R, Metzler M (1979) High-pressure, reverse-phase partition chromatography separation of diethylstilbestrol metabolites and analogs. Anal Biochem 92: 199–202
Ham EA, Cirillo VJ, Zanetti ME, Kuehl FA Jr (1975) Estrogen-directed synthesis of specific prostaglandins in uterus. Proc Natl Acad Sci USA 72: 1420–1424
Helton ED, Goldzieher JW (1977) Metabolism of ethynyl estrogens. J Toxicol Environ Health 3: 231–241
Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878–881
Hill A, Wolff S (1982) Increased induction of sister chromatid exchange by diethylstilbestrol in lymphocytes from pregnant and premenopausal women. Cancer Res 42: 893–896
IARC (1979) Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Sex Hormones, Vol 21, International Agency for Research on Cancer, Lyon, France
Jaggi W, Lutz WK, Schlatter C (1978) Covalent binding of ethinylestradiol and estrone to rat liver DNA in vivo. Chem Biol Interact 23: 13–18
Jellinck PH, Brown BJ (1971) A simple enzymatic method for the synthesis of 2-hydroxy-(4-14C)estradiol. Steroids 17: 133–140
Jick H, Walker AM, Rothman KJ (1980) The epidemic of endometrial cancer: A commentary. Am J Public Health 70: 264–267
Kappus H, Sies H (1981) Toxic drug effects associated with oxygen metabolism: Redox cycling and lipid peroxidation. Experientia 37: 1233–1241
Lang R, Redmann U (1979) Non-mutagenicity of some sex hormones in the Salmonella/microsome mutagenicity test. Mutat Res 67: 361–365
Li SA, Li JJ (1981) Changes in estrogen receptor levels during DES-induced hepatocarcinogenesis in the Syrian hamster fed α-naphthoflavone. J Steroid Biochem 15: 387–392
Li JJ, Li SA (1984) Estrogen-induced tumorigenesis in hamsters: roles for hormonal and carcinogenic activities. Arch Toxicol 55: 110–118
Liehr JG (1983) 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol Pharmacol 23: 278–281
Lillehaug JR, Djurhuus R (1982) Effect of diethylstilbestrol on the transformable mouse embryo fibroblast C3H/10T1/2C18 cells. Tumor promotion, cell growth, DNA synthesis, and ornithine decarboxylase. Carcinogenesis 3: 797–799
Lutz WK, Jaggi W, Schlatter C (1982) Covalent binding of diethylstilbestrol to DNA in rat and hamster liver and kidney. Chem Biol Interact 42: 251–257
Lyttle CR, DeSombre ER (1977) Generality of oestrogen stimulation of peroxidase activity in growth responsive tissues. Nature 268: 337–339
Marks F, Hecker E (1969) Metabolism and mechanism of action of oestrogens. XII. Structure and mechanism of formation of water-soluble and protein-bound metabolites of oestrone in rat-liver microsomes in vitro and in vivo. Biochim Biophys Acta 187: 250–265
Martin CN, McDermid AC, Garner RC (1978) Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res 38: 2621–2627
Maydl R, Newbold RR, Metzler M, McLachlan JA (1983) Diethylstilbestrol metabolism by the fetal genital tract. Endocrinology 113: 146–151
McLachlan JA, Wong A, Degen GH, Barrett JC (1982) Morphological and neoplastic transformation of Syrian hamster embryo fibroblasts by diethylstilbestrol and its analogs. Cancer Res 42: 3040–3045
Mehta RD, von Borstel RC (1982) Genetic activity of diethylstilbestrol in Saccharomyces cerevisiae. Enhancement of mutagenicity by oxidizing agents. Mutat Res 92: 49–61
Metzler M (1976) Metabolic activation of carcinogenic diethylstilbestrol in rodents and humans. J Toxicol Environ Health Suppl 1: 21–35
Metzler M (1981) The metabolism of diethylstilbestrol. CRC Crit Rev Biochem 10: 171–212
Metzler M, Gottschlich R, McLachlan JA (1980) Oxidative metabolism of stilbene estrogens, In: McLachlan JA (ed) Estrogens in the environment. Elsevier/North-Holland Biomedical Press, New York, pp 293–303
Metzler M, McLachlan JA (1978a) Proposed nomenclature for diethylstilbestrol metabolites. J Environ Pathol Toxicol 2: 579–582
Metzler M, McLachlan JA (1978b) Oxidative metabolism of diethylstilbestrol and steroidal estrogens as a potential factor in their fetotoxicity, In: Neubert D, Merker H-J, Nau H, Langman J (eds) Role of pharmacokinetics in prenatal and perinatal toxicology. Georg Thieme Publishers, Stuttgart, pp 157–164
Metzler M, McLachlan JA (1978c) Peroxidase-mediated oxidation, a possible pathway for metabolic activation of diethylstilbestrol. Biochem Biophys Res Comm 85: 874–884
Pienta RJ (1980) Transformation of Syrian hamster embryo cells by diverse chemicals and correlation with their reported carcinogenic and mutagenic activities, In: deSerres FJ, Hollaender A (eds) Chemical Mutagens. Plenum Publishing Corp., New York, pp 175–202
Purdy RH, Meltz ML, Goldzieher JW, Goodwin TJ, Williams MJ (1980) Chemical transformation by estrogens in a mammalian cell culture system. Proc 62nd Annual Meeting of the Endocrine Society, Washington, DC, p 217
Rüdiger HW, Haenisch F, Metzler M, Oesch F, Glatt HR (1979) Metabolites of diethylstilboestrol induce sister chromatid exchange in human cultured fibroblasts. Nature 281: 392–394
Tsibris JCM, McGuire PM (1977) Microsomal activation of estrogens and binding to nucleic acids and proteins. Biochem Biophys Res Commun 78: 411–417
Tsutsui T, Degen GH, Schiffmann D, Wong A, Maizumi H, McLachlan JA, Barrett JC (1984) Dependence on exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds. Cancer Res 44: 184–189
Tsutsui T, Maizumi H, McLachlan JA, Barrett JC (1983) Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosomal mechanism in carcinogenesis. Cancer Res 43: 3814–3821
Vana J, Murphy GP, Aronoff BL, Baker HW (1979) Survey of primary liver tumors and oral contraceptive use. J Toxicol Environ Health 5: 255–273
Yager JD Jr, Fifield DS Jr (1982) Lack of hepatogenotoxicity of oral contraceptive steroids. Carcinogenesis 3: 625–628
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Metzler, M. Metabolism of stilbene estrogens and steroidal estrogens in relation to carcinogenicity. Arch Toxicol 55, 104–109 (1984). https://doi.org/10.1007/BF00346047
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00346047